---
title: "Monte Rosa Therapeutics grants inducement awards to new hires, including options for 18,025 shares at $24.02"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291583232.md"
description: "Monte Rosa Therapeutics granted inducement equity awards to three new non-executive hires under its 2026 Inducement Plan. The package includes 18,025 non-qualified stock options priced at $24.02 per share and 3,900 restricted stock units. Options vest 25% after one year, then monthly over three years, while RSUs vest annually over four years."
datetime: "2026-07-02T20:01:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291583232.md)
  - [en](https://longbridge.com/en/news/291583232.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291583232.md)
---

# Monte Rosa Therapeutics grants inducement awards to new hires, including options for 18,025 shares at $24.02

-   Monte Rosa disclosed inducement equity awards to three newly hired non-executive employees under its 2026 Inducement Plan. \* Grants total 18,025 non-qualified stock options priced at $24.02 per share, based on the July 1 Nasdaq close. \* Options vest 25% after one year, then in 36 equal monthly installments, subject to continued service. \* The package also includes 3,900 restricted stock units vesting 25% on each of the first four anniversaries. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Monte Rosa Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607021601PRIMZONEFULLFEED9756416) on July 02, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [GLUE.US](https://longbridge.com/en/quote/GLUE.US.md)

## Related News & Research

- [Buy Rating Maintained on Monte Rosa as Diversified Degrader Pipeline and Novartis Partnership Offset ZEUS Cardiovascular Setback](https://longbridge.com/en/news/294546249.md)
- [Monte Rosa CEO Markus Warmuth sells 9,500 shares worth $220,219.55](https://longbridge.com/en/news/293070500.md)
- [Twist Bioscience grants 44,434 RSUs to 24 new hires under inducement equity plan](https://longbridge.com/en/news/294820275.md)
- [Recursion grants 3,234,866 inducement RSUs to 24 new hires under 2024 equity plan](https://longbridge.com/en/news/294552733.md)
- [Morgan Stanley says to snatch up these 24 AI-adopter stocks as their profit margins balloon](https://longbridge.com/en/news/294809509.md)